Green Cross Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 3,695.00
+15.00 (0.41%)
At close: Apr 10, 2026
KOSDAQ:142280 Market Cap
KOSDAQ:142280 has a market cap or net worth of 80.34 billion as of April 10, 2026. Its market cap has decreased by -6.66% in one year.
Market Cap
80.34B
Enterprise Value
99.42B
Revenue
108.41B
Ranking
n/a
PE Ratio
25.31
Stock Price
3,695.00
Market Cap Chart
Since December 17, 2014, KOSDAQ:142280's market cap has decreased from 98.95B to 80.34B, a decrease of -18.81%. That is a compound annual growth rate of -1.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 80.01B | -8.11% |
| Dec 30, 2025 | 87.08B | 12.05% |
| Dec 30, 2024 | 77.71B | -22.72% |
| Dec 28, 2023 | 100.56B | -17.47% |
| Dec 29, 2022 | 121.86B | -20.00% |
| Dec 30, 2021 | 152.32B | -53.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 456.71B |
| 3billion | 362.08B |
| GENINUS | 160.24B |
| HLB Panagene | 104.36B |
| Cytogen | 88.47B |
| Protia | 57.43B |
| Seoulin Bioscience | 53.40B |
| GeneMatrix | 38.73B |